Published in Eur J Clin Invest on February 01, 1988
G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation. Am J Pathol (2008) 1.60
Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol (2003) 1.57
Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest (1990) 1.36
Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J Pathol (2012) 1.21
UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res (1991) 1.17
Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther (2011) 1.09
Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis (2001) 1.06
Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin Rheumatol (2011) 1.03
Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta. J Clin Invest (1994) 1.03
Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis. Ann Rheum Dis (2005) 1.01
Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum (2013) 0.98
Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes. J Clin Invest (1992) 0.96
Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers. Clin Exp Immunol (1998) 0.95
Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis. Clin Rheumatol (2012) 0.91
Retracted Mithramycin selectively inhibits collagen-alpha 1(I) gene expression in human fibroblast. J Clin Invest (1993) 0.91
Altered procollagen mRNA expression during the progression of avian scleroderma. Mol Med (1997) 0.88
mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis. Arthritis Res Ther (2011) 0.87
Role of cytokines in controlling connective tissue gene expression. Arch Dermatol Res (1994) 0.83
Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Ann Rheum Dis (2006) 0.80
Current perspectives on the immunopathogenesis of systemic sclerosis. Immunotargets Ther (2016) 0.79
Matrix remodeling in systemic sclerosis. Semin Immunopathol (2015) 0.78
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2. Arthritis Res Ther (2015) 0.77
An automatic analysis method for in situ hybridization using high-resolution image analysis. Arch Dermatol Res (1989) 0.77
Enhanced production of transforming growth factor-beta (TGF-beta) during autologous mixed lymphocyte reaction of systemic sclerosis patients. Clin Exp Immunol (1995) 0.77
Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosis. Clin Rheumatol (2012) 0.76
The role of the acquired immune response in systemic sclerosis. Semin Immunopathol (2015) 0.75
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (1994) 3.07
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci (1998) 2.60
Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23
Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol (1991) 2.08
Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci (2000) 1.92
Biosynthesis of two subunits of type IV procollagen and of other basement membrane proteins by a human tumor cell line. Eur J Biochem (1980) 1.90
Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol (1995) 1.82
Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures. J Biol Chem (1979) 1.80
Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice. Proc Natl Acad Sci U S A (1993) 1.68
Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol (1981) 1.58
Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol (2000) 1.51
Increased deposition of fibulin-2 in solar elastosis and its colocalization with elastic fibres. Br J Dermatol (2001) 1.51
Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol (2004) 1.49
Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma. Arch Dermatol (1997) 1.49
Fibroblasts in mechanically stressed collagen lattices assume a "synthetic" phenotype. J Biol Chem (2001) 1.49
Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition. Proc Natl Acad Sci U S A (1997) 1.47
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer (2002) 1.45
Common structural features of the genes for two stable RNAs from Halobacterium halobium. Nucleic Acids Res (1985) 1.45
Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) (2009) 1.44
Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol (2000) 1.43
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40
Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest (1990) 1.36
Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res (1998) 1.33
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum (2004) 1.29
Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med (Berl) (1998) 1.28
Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat Genet (1997) 1.25
Regulation of collagen synthesis in fibroblasts within a three-dimensional collagen gel. Exp Cell Res (1988) 1.24
Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22
Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol (2000) 1.19
Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur J Biochem (1991) 1.19
Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. J Biol Chem (1993) 1.18
UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res (1991) 1.17
The absence of nidogen 1 does not affect murine basement membrane formation. Mol Cell Biol (2000) 1.17
Type III procollagen is the major collageneous component produced by a continuous rhabdomyosarcoma cell line. FEBS Lett (1979) 1.16
Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum (1990) 1.14
Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem (1999) 1.13
Localization of collagen alpha 1(I) gene expression during wound healing by in situ hybridization. J Invest Dermatol (1989) 1.12
Extracellular matrix components synthesized by human amniotic epithelial cells in culture. Cell (1980) 1.12
Disorder of collagen metabolism in a patient with osteogenesis imperfecta (lethal type): increased degree of hydroxylation of lysine in collagen types I and III. Eur J Clin Invest (1981) 1.11
Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels. J Invest Dermatol (1998) 1.09
Expanding the keratin mutation database: novel and recurrent mutations and genotype-phenotype correlations in 28 patients with epidermolytic ichthyosis. Br J Dermatol (2011) 1.07
UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol (1994) 1.07
Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol (2000) 1.06
Collagen biosynthesis in systemic scleroderma: regulation of posttranslational modifications and synthesis of procollagen in cultured fibroblasts. J Invest Dermatol (1985) 1.06
Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol (1999) 1.05
Downregulation of collagen synthesis in fibroblasts within three-dimensional collagen lattices involves transcriptional and posttranscriptional mechanisms. FEBS Lett (1993) 1.03
Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma? Matrix Biol (2005) 1.03
Osteogenesis imperfecta: biochemical and clinical evaluation of 13 cases. Klin Wochenschr (1981) 1.02
The marfan's syndrome. In vitro study of collagen metabolism in tissue specimens of the aorta. Exp Cell Biol (1977) 1.02
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol (2009) 1.01
Aminoterminal extension peptides from type I procollagen normalize excessive collagen synthesis of scleroderma fibroblasts. Arch Dermatol Res (1978) 1.01
Immunofluorescent localization of type IV collagen and laminin in human skin and its application in junctional zone pathology. Br J Dermatol (1982) 1.01
Caffeine hypersensitivity. Allergy (2002) 1.01
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. Rheumatology (Oxford) (2009) 1.01
Letters: Fibroblasts from a patient with scleroderma reveal abnormal metabolism. Arch Dermatol Res (1977) 1.01
Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. J Invest Dermatol (1991) 1.00
Synthesis of collagen by human fibroblasts and their SV40 transformants. Exp Cell Res (1980) 1.00
Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen. FEBS Lett (1989) 1.00
Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Gut (1992) 1.00
Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma. J Invest Dermatol (1986) 1.00
Down-regulation of alpha 3(VI) chain expression by gamma-interferon decreases synthesis and deposition of collagen type VI. Eur J Biochem (1989) 0.99
Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma. J Dermatol Sci (1999) 0.99
Influence of corticosteroids on chemotactic response and collagen metabolism of human skin fibroblasts. Biochem Pharmacol (1988) 0.98
Inhibition of fibroblast chemotaxis by superoxide dismutase. Eur J Cell Biol (1987) 0.98
Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol (2005) 0.98
Regulation of collagen VI expression in fibroblasts. Effects of cell density, cell-matrix interactions, and chemical transformation. J Biol Chem (1989) 0.97
Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J (1996) 0.97
Changes in calcium and collagen IV binding caused by mutations in the EF hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin). J Mol Biol (1994) 0.96
Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun (2001) 0.96
Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis. J Dermatol Sci (2001) 0.96
Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma. J Invest Dermatol (1995) 0.96
Fibromatosis hyalinica multiplex (juvenile hyalin fibromatosis). Light microscopic, electron microscopic, immunohistochemical, and biochemical findings. Cancer (1985) 0.96
Mg2+ and Ca2+ differentially regulate beta 1 integrin-mediated adhesion of dermal fibroblasts and keratinocytes to various extracellular matrix proteins. Exp Cell Res (1994) 0.95
Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments. Coll Relat Res (1983) 0.95
Collagen type distribution and macromolecular organization of connective tissue in different layers of human skin. J Invest Dermatol (1984) 0.95
A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription. Matrix Biol (1995) 0.95
Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis. Springer Semin Immunopathol (1999) 0.94
The hemidesmosomal plaque. I. Characterization of a major constituent protein as a differentiation marker for certain forms of epithelia. Differentiation (1990) 0.94
Cloning and complete amino acid sequences of human and murine basement membrane protein BM-40 (SPARC, osteonectin). FEBS Lett (1988) 0.94
Psoralen photoactivation promotes morphological and functional changes in fibroblasts in vitro reminiscent of cellular senescence. J Cell Sci (1998) 0.94
Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol (1999) 0.94
Structure of basement membranes in malignant melanoma and nevocytic nevi. J Invest Dermatol (1989) 0.93
Laminins: a family of diverse multifunctional molecules of basement membranes. J Invest Dermatol (1996) 0.93
Contraction-dependent apoptosis of normal dermal fibroblasts. J Invest Dermatol (2001) 0.92
Influence of cell density on collagen biosynthesis in fibroblast cultures. Biochem J (1982) 0.92
Pathomorphological and biochemical alterations in Ehlers-Danlos-syndrome type IV. Pathol Res Pract (1994) 0.92
Immunofluorescence analysis of collagen, fibronectin, and basement membrane protein in scleroderma skin. J Invest Dermatol (1980) 0.92
Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol (2003) 0.92
[Long time HCB exposition of rats: influence on the porphyrin excretion in the urine and on the cytochrome P-450 in the liver (author's transl)]. Arch Dermatol Res (1977) 0.92
Biochemical characteristics of Ehlers-Danlos syndrome type VI in a family with one affected infant. Hum Genet (1979) 0.92
Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on collagen synthesis of human skin fibroblasts in vitro. Exp Cell Res (1989) 0.92
Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis. Genes Immun (2003) 0.91
Regulation of connective tissue homeostasis in the skin by mechanical forces. Clin Exp Rheumatol (2004) 0.91